yes but they have always wanted the best deal and that will materialize once the potential partners are happy that their decision will be a wise investment....... that is once the fda approve p3 ....once they have approved it things will hot up and we all get a better value for the company.......
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $123.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 30.0¢ | $81.44K | 265.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 73091 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 216621 | 4 |
View Market Depth
| Last trade - 15.03pm 12/08/2025 (20 minute delay) ? |
| PAR (ASX) Chart |